tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MRUS Stock Latest News

Merus’s Breakthrough in HNSCC: Buy Rating Backed by FDA Support and Promising Trial Data
RatingsMerus’s Breakthrough in HNSCC: Buy Rating Backed by FDA Support and Promising Trial Data
3d ago
MRUS
Merus’s Breakthrough Therapy Designation and Strong Financials Justify Buy Rating
PremiumRatings
Merus’s Breakthrough Therapy Designation and Strong Financials Justify Buy Rating
4d ago
MRUS
Merus’ petosemtamab granted Breakthrough Therapy designation by FDA
PremiumThe Fly
Merus’ petosemtamab granted Breakthrough Therapy designation by FDA
4d ago
MRUS
Target downgraded, Cisco upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Target downgraded, Cisco upgraded: Wall Street’s top analyst calls
9d ago
M
AS
Analyst Recommends Buy for Merus Based on Promising Petosemtamab Developments and Revenue Potential
PremiumRatings
Analyst Recommends Buy for Merus Based on Promising Petosemtamab Developments and Revenue Potential
9d ago
MRUS
Merus initiated with an Overweight at Piper Sandler
PremiumThe FlyMerus initiated with an Overweight at Piper Sandler
9d ago
MRUS
Roblox downgraded, Pinterest upgraded: Wall Street’s top analyst calls
Premium
The Fly
Roblox downgraded, Pinterest upgraded: Wall Street’s top analyst calls
15d ago
PH
ELF
Merus initiated with an Overweight at Wells Fargo
Premium
The Fly
Merus initiated with an Overweight at Wells Fargo
15d ago
MRUS
Biohaven enters multi-target collaboration with Merus
PremiumThe Fly
Biohaven enters multi-target collaboration with Merus
1M ago
BHVN
MRUS
Biohaven, Merus enter research pact and license agreement to develop three ADCs
PremiumThe Fly
Biohaven, Merus enter research pact and license agreement to develop three ADCs
1M ago
BHVN
MRUS
Merus doses first patient in petosemtamab trial
PremiumThe Fly
Merus doses first patient in petosemtamab trial
2M ago
MRUS
Merus price target raised to $97 from $89 at Citi
PremiumThe Fly
Merus price target raised to $97 from $89 at Citi
2M ago
MRUS
3 Best Stocks to Buy Now, 12/6/2024, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 12/6/2024, According to Top Analysts
3M ago
BLZE
MRUS
Merus gets FDA approval of BIZENGRI in NRG1+ Pancreatic Adenocarcinoma, NSCLC
Premium
The Fly
Merus gets FDA approval of BIZENGRI in NRG1+ Pancreatic Adenocarcinoma, NSCLC
3M ago
MRUS
Merus’ zenocutuzumab-zbco granted accelerated approval by FDA
Premium
The Fly
Merus’ zenocutuzumab-zbco granted accelerated approval by FDA
3M ago
MRUS
Merus price target lowered to $109 from $111 at Guggenheim
PremiumThe Fly
Merus price target lowered to $109 from $111 at Guggenheim
3M ago
MRUS
Merus, Partner Therapeutics enter agreement for Zenocutuzumab commercialization
PremiumThe Fly
Merus, Partner Therapeutics enter agreement for Zenocutuzumab commercialization
3M ago
MRUS
Merus initiated with a Buy at Goldman Sachs
PremiumThe Fly
Merus initiated with a Buy at Goldman Sachs
3M ago
MRUS
Merus management to meet with Truist
PremiumThe Fly
Merus management to meet with Truist
3M ago
MRUS
Merus N.V. Reports Q3 2024 Financial Results
PremiumCompany AnnouncementsMerus N.V. Reports Q3 2024 Financial Results
4M ago
MRUS
Merus reports Q3 EPS ($1.46), consensus (88c)
Premium
The Fly
Merus reports Q3 EPS ($1.46), consensus (88c)
4M ago
MRUS
Merus sees cash runway into 2028
Premium
The Fly
Merus sees cash runway into 2028
4M ago
MRUS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >